StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
IXICO plc
LSE:IXI.L
Sector
Location
Market Cap
USD 14.39 M
Share Price
USD 0.16
Avg Daily Volume
67,240
Change (1 day)
8.93%
Change (1 year)
71.91%
Change (YTD)
5.64%
IXICO plc Selling, General, and Administrative Expenses (SG&A) for the year ending September 30, 2024: USD 5.76 M
IXICO plc Selling, General, and Administrative Expenses (SG&A) is USD 5.76 M for the year ending September 30, 2024, a 13.12% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.
-
IXICO plc Selling, General, and Administrative Expenses (SG&A) for the year ending September 30, 2023 was USD 5.09 M, a 32.71% change year over year.
-
IXICO plc Selling, General, and Administrative Expenses (SG&A) for the year ending September 30, 2022 was USD 3.84 M, a -20.73% change year over year.
-
IXICO plc Selling, General, and Administrative Expenses (SG&A) for the year ending September 30, 2021 was USD 4.84 M, a -14.03% change year over year.
-
IXICO plc Selling, General, and Administrative Expenses (SG&A) for the year ending September 30, 2020 was USD 5.63 M, a 9.69% change year over year.
Competitors
Natera, Inc.
USD 141.06
NTRA
+3.25
2.35%
Veracyte, Inc.
USD 23.59
VCYT
-0.62
-2.56%
Boston Scientific Corporation
USD 106.21
BSX
-1.55
-1.44%
RELX Plc
USD 53.64
REL.L
+0.75
1.42%
Siemens Healthineers AG
USD 56.26
SHL.DE
+1.52
2.77%
Cencora, Inc.
USD 290.45
COR
-2.99
-1.02%
Edwards Lifesciences Corporation
USD 75.80
EW
-1.11
-1.44%
GE HealthCare Technologies Inc.
USD 76.77
GEHC
-0.48
-0.62%
DexCom, Inc.
USD 86.74
DXCM
+0.31
0.36%
IQVIA Holdings Inc.
USD 200.82
IQV
+6.58
3.39%
Laboratory Corporation of America Holdings
USD 267.69
LH
+17.18
6.86%
Illumina, Inc.
USD 107.64
ILMN
+3.03
2.90%
Somnigroup International Inc
USD 73.88
SGI
-1.12
-1.49%
Hologic, Inc.
USD 66.10
HOLX
+0.15
0.23%
Baxter International Inc.
USD 28.77
BAX
+0.21
0.73%
Torrent Pharmaceuticals Limited
USD 41.46
TORNTPHARM.NS
+0.76
1.87%
ICON Public Limited Company
USD 195.01
ICLR
+27.12
16.15%
Fisher & Paykel Healthcare Corporation Limited
USD 21.90
FPH.NZ
-0.11
-0.51%
Zydus Lifesciences Limited
USD 11.28
ZYDUSLIFE.NS
+0.05
0.46%
Tempus AI, Inc.
USD 63.34
TEM
-1.52
-2.34%
Key Data
| Date | Selling, General, and Administrative Expenses (SG&A) | Research and Development (R&D) Expenses | Revenue | Revenue |
|---|
Competitors
Natera, Inc.
USD 141.06
NTRA
+3.25
2.35%
Veracyte, Inc.
USD 23.59
VCYT
-0.62
-2.56%
Boston Scientific Corporation
USD 106.21
BSX
-1.55
-1.44%
RELX Plc
USD 53.64
REL.L
+0.75
1.42%
Siemens Healthineers AG
USD 56.26
SHL.DE
+1.52
2.77%
Cencora, Inc.
USD 290.45
COR
-2.99
-1.02%
Edwards Lifesciences Corporation
USD 75.80
EW
-1.11
-1.44%
GE HealthCare Technologies Inc.
USD 76.77
GEHC
-0.48
-0.62%
DexCom, Inc.
USD 86.74
DXCM
+0.31
0.36%
IQVIA Holdings Inc.
USD 200.82
IQV
+6.58
3.39%
Laboratory Corporation of America Holdings
USD 267.69
LH
+17.18
6.86%
Illumina, Inc.
USD 107.64
ILMN
+3.03
2.90%
Somnigroup International Inc
USD 73.88
SGI
-1.12
-1.49%
Hologic, Inc.
USD 66.10
HOLX
+0.15
0.23%
Baxter International Inc.
USD 28.77
BAX
+0.21
0.73%
Torrent Pharmaceuticals Limited
USD 41.46
TORNTPHARM.NS
+0.76
1.87%
ICON Public Limited Company
USD 195.01
ICLR
+27.12
16.15%
Fisher & Paykel Healthcare Corporation Limited
USD 21.90
FPH.NZ
-0.11
-0.51%
Zydus Lifesciences Limited
USD 11.28
ZYDUSLIFE.NS
+0.05
0.46%
Tempus AI, Inc.
USD 63.34
TEM
-1.52
-2.34%